uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

NCT02964988 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Recruitment issues and interim results

Conditions

Prostate Cancer Metastatic
Bone Metastases

Interventions

DRUG: Injection of PET tracer 68Ga-NOTA-AE105
DEVICE: PET/CT

Sponsor

Rigshospitalet, Denmark